Contact Information
13101 Allen Road , Southgate, Michigan 48195, United States
Detailed Information
Guidance Center Building 4
-
Services:
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Sign language services for the deaf and hard of hearing
- Adults
- Young Adults
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Acamprosate (CampralĀ®)
- Buprenorphine (extended-release, injectable)
- Medication for mental disorders
- Clonidine
- Naltrexone (oral)
- Nicotine replacement
- Disulfiram
- Private non-profit organization
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Matrix Model
- Cognitive behavioral therapy
- Anger management
- Motivational interviewing
- Relapse prevention
- Smoking not permitted
- Clients with co-occurring mental and substance use disorders
- Medicare
- SAMHSA funding/block grants
- Medicaid
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- Case management service
- Integrated primary care services
- Suicide prevention services
- Transportation assistance
- Mental health services
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Individual counseling
- Substance use disorder education
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Assistance with obtaining social services
- Mentoring/peer support
- Recovery coach
- Housing services
- Employment counseling or training
- This facility administers/prescribes medication for alcohol use disorder
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Intensive outpatient treatment
- Outpatient
- Vaping not permitted
- State Substance use treatment agency
- The Joint Commission
- Discharge Planning
- Outcome follow-up after discharge
- Naloxone and overdose education
- Screening for substance use
- Screening for tobacco use
- Outreach to persons in the community
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Interim services for clients
- Screening for mental disorders
- Female
- Male
- Treatment for other addiction disorder
- Buprenorphine maintenance
- Prescribes naltrexone
- Prescribes buprenorphine
Type of Care
Language Services
Age Groups Accepted
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Treatment Approaches
Facility Smoking Policy
Special Programs/Groups Offered
Payment/Insurance/Funding Accepted
Opioid Medications used in Treatment
Testing
Ancillary Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Education and Counseling Services
Recovery Support Services
Type of Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Vaping Policy
License/Certification/Accreditation
Transitional Services
Assessment/Pre-treatment
Gender Accepted
Other Services
Type of Opioid Treatment
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm